Peña, L. D. M., Burrage, L. C., Enns, G. M., Esplin, E. D., Harding, C., Mendell, J. R., … ACMG Therapeutics Committee. Electronic address: documents@acmg.net. (2023). Contributions from medical geneticists in clinical trials of genetic therapies: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med, 25(6), 100831. https://doi.org/10.1016/j.gim.2023.100831

Peña, Loren D. M., Lindsay C. Burrage, Gregory M. Enns, Edward D. Esplin, Cary Harding, Jerry R. Mendell, Zhiyv Neal Niu, et al. “Contributions from medical geneticists in clinical trials of genetic therapies: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG).” Genet Med 25, no. 6 (June 2023): 100831. https://doi.org/10.1016/j.gim.2023.100831.

Peña LDM, Burrage LC, Enns GM, Esplin ED, Harding C, Mendell JR, et al. Contributions from medical geneticists in clinical trials of genetic therapies: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2023 Jun;25(6):100831.

Peña, Loren D. M., et al. “Contributions from medical geneticists in clinical trials of genetic therapies: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG).” Genet Med, vol. 25, no. 6, June 2023, p. 100831. Pubmed, doi:10.1016/j.gim.2023.100831.

Peña LDM, Burrage LC, Enns GM, Esplin ED, Harding C, Mendell JR, Niu ZN, Scharfe C, Yu T, Koeberl DD, ACMG Therapeutics Committee. Electronic address: documents@acmg.net. Contributions from medical geneticists in clinical trials of genetic therapies: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2023 Jun;25(6):100831.